Delivery Order 75N91018D00020-75N91020F00001
Award Date 8/1/20
Potential Completion Date 6/30/25
Potential Value $20M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Detroit, MI 48202, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the National Cancer Institute, a civilian federal agency, to Henry Ford Health System, a non-profit integrated healthcare provider and research organization. The contract, valued at $857,850.52, is for continued infrastructure setup and is part of a larger indefinite delivery, indefinite quantity (IDIQ) master agreement focused on cancer study cohort recruitment. The contract does not have a set-aside designation. Through this task order, Henry Ford...
- This is a $866,368.00 delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to Henry Ford Health System, a non-profit health care organization based in Detroit, Michigan. The contract is for the setup and recruitment of participants for a cancer study cohort in Detroit over a five-year period. This delivery order is part of a larger Cancer Study Cohort Recruitment master contract vehicle with NIH. The contract does not have a set-aside designation. As a...
- This is a definitive $202,108 firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the non-profit Henry Ford Health System (doing business as Henry Ford Hospital) in Detroit, Michigan. The contract does not have a set-aside designation. Under this contract, Henry Ford Health System will provide medical services and supplies, potentially including laboratory testing, radiology services, disease screening, and other...
- This is a Firm Fixed Price Delivery Order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Wayne State University in Detroit, Michigan. The contract is for a pilot study to determine the feasibility of obtaining patient-reported outcomes from cancer survivors to enhance SEER (Surveillance, Epidemiology, and End Results) registries. The period of performance is from September 19, 2016 to September 18, 2017, with a ceiling value of...
- This is a firm fixed price delivery order contract awarded to the Fred Hutchinson Cancer Research Center, a non-profit organization, by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for the Patterns of Care (POC)/Quality of Care Study, which will analyze non-small cell lung cancer (NSCLC) diagnosis data from 2017 and NSCLC and melanoma diagnosis data from 2018. The contract has a potential value of $85,626.00 and was awarded...
- The National Cancer Institute (NCI) awarded a $35.0 million Delivery Order to Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) contractor, on August 31, 2019, under the FFRDC Moonshot Portfolio Task Order. The contract operates on a Cost Plus Fixed Fee basis with no set-aside designation and an ultimate completion date of September 30, 2026. Work is performed at the contractor's Frederick, Maryland facility. As an FFRDC operator for the NCI, Leidos...
- This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Fred Hutchinson Cancer Research Center, a non-profit organization. The $52,423 contract is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) program and is intended to improve the completeness of treatment and other key data elements by linking 15-month resubmitted data from Commission on Cancer (CoC) hospitals. The contract has an ultimate completion...
- This is a delivery order contract awarded by the National Cancer Institute to Alliance For Advancing Biomedical Research, a non-profit organization, for a Transition Task Order for a Federally Funded Research and Development Center (FFRDC) contract. The contract has a ceiling value of $2,000,000.00 and is a firm fixed price contract. The contract supports the implementation of the President's Department of Government Efficiency Cost Efficiency Initiative. This contract is not set aside and is...
- This $11,541,930.00 delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to the University of Chicago. The contract supports the "PREPARATION AND STUDY LAUNCH" for a Cancer Study Cohort Recruitment effort, which is the parent indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The award has a period of performance through July 6, 2025 and does not have a set-aside designation. The...